Home/Filings/4/0001209191-24-003970
4//SEC Filing

Rona Jeffrey A 4

Accession 0001209191-24-003970

CIK 0001636651other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 6:03 PM ET

Size

7.6 KB

Accession

0001209191-24-003970

Insider Transaction Report

Form 4
Period: 2024-02-22
Transactions
  • Award

    Common Stock

    2024-02-22+28,12528,125 total
  • Award

    Stock Option (Right to Buy)

    2024-02-22+168,7500 total
    Exercise: $3.68Exp: 2034-02-21Common Stock (168,750 underlying)
Footnotes (3)
  • [F1]Represents a restricted stock unit (RSU) award. One-third (1/3) of the total number of RSUs shall vest on January 1, 2025 and one-third (1/3) of the remaining RSUs shall vest each year thereafter on anniversary of the vesting commencement date, subject to the Reporting Person's continuous service through such vesting date.
  • [F2]Each RSU represents a contingent right to receive one share of Common Stock.
  • [F3]25% of the shares subject to the Stock Option will vest and become exercisable on February 22, 2025 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued services through such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001311404

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 6:03 PM ET
Size
7.6 KB